Mattoo S, Cherry J
Clin Microbiol Rev. 2005; 18(2):326-82.
PMID: 15831828
PMC: 1082800.
DOI: 10.1128/CMR.18.2.326-382.2005.
McClelland E, Granger D, Potts W
Infect Immun. 2003; 71(8):4815-7.
PMID: 12874366
PMC: 166009.
DOI: 10.1128/IAI.71.8.4815-4817.2003.
Buchanan K, Murphy J
Infect Immun. 1993; 61(7):2854-65.
PMID: 8514388
PMC: 280931.
DOI: 10.1128/iai.61.7.2854-2865.1993.
Mukherjee J, Scharff M, Casadevall A
Infect Immun. 1995; 63(9):3353-9.
PMID: 7642262
PMC: 173461.
DOI: 10.1128/iai.63.9.3353-3359.1995.
Fromtling R, Shadomy H
Mycopathologia. 1982; 77(3):183-90.
PMID: 7040977
DOI: 10.1007/BF00518804.
Transfer of immunity to cryptococcosis by T-enriched splenic lymphocytes from Cryptococcus neoformans-sensitized mice.
Lim T, Murphy J
Infect Immun. 1980; 30(1):5-11.
PMID: 7002791
PMC: 551268.
DOI: 10.1128/iai.30.1.5-11.1980.
Resistance to challenge and macrophage activity in mice previously vaccinated with formalin-killed Cryptococcus neoformans.
Anderson D, Dykstra M
Mycopathologia. 1984; 86(3):169-77.
PMID: 6382015
DOI: 10.1007/BF00441128.
Role of macrophages in resistance of mice to experimental cryptococcosis.
Monga D
Infect Immun. 1981; 32(3):975-8.
PMID: 6265377
PMC: 351546.
DOI: 10.1128/iai.32.3.975-978.1981.
Experimentally induced immunity in the mycoses.
Kong Y, LEVINE H
Bacteriol Rev. 1967; 31(1):35-53.
PMID: 4962952
PMC: 441021.
DOI: 10.1128/br.31.1.35-53.1967.
Cryptococcus neoformans. 3. Inhibition of phagocytosis.
Bulmer G, Sans M
J Bacteriol. 1968; 95(1):5-8.
PMID: 4866104
PMC: 251963.
DOI: 10.1128/jb.95.1.5-8.1968.
Cryptococcus neoformans. II. Phagocytosis by human leukocytes.
Bulmer G, Sans M
J Bacteriol. 1967; 94(5):1480-3.
PMID: 4862192
PMC: 276851.
DOI: 10.1128/jb.94.5.1480-1483.1967.
Skin testing of guinea pigs and footpad testing of mice with a new antigen for detecting delayed hypersensitivity to Cryptococcus neoformans.
Murphy J, Gregory J, LARSH H
Infect Immun. 1974; 9(2):404-9.
PMID: 4593343
PMC: 414817.
DOI: 10.1128/iai.9.2.404-409.1974.
Protection of mice against experimental cryptococcosis by anti-Cryptococcus neoformans monoclonal antibody.
Dromer F, Charreire J, Contrepois A, Carbon C, Yeni P
Infect Immun. 1987; 55(3):749-52.
PMID: 3546140
PMC: 260405.
DOI: 10.1128/iai.55.3.749-752.1987.
Inhibition of phagocytosis by cryptococcal polysaccharide: dissociation of the attachment and ingestion phases of phagocytosis.
Kozel T, Mastroianni R
Infect Immun. 1976; 14(1):62-7.
PMID: 780279
PMC: 420844.
DOI: 10.1128/iai.14.1.62-67.1976.
Pathogenesis, lethality, and immunizing effect of experimental cutaneous cryptococcosis.
Dykstra M, Friedman L
Infect Immun. 1978; 20(2):446-55.
PMID: 352944
PMC: 421876.
DOI: 10.1128/iai.20.2.446-455.1978.
Histopathological studies on experimental cryptococcosis in nude mice.
Nishimura K, Miyaji M
Mycopathologia. 1979; 68(3):145-53.
PMID: 316872
DOI: 10.1007/BF00578522.
Response of congenitally athymic (nude) and phenotypically normal mice to Cryptococcus neoformans infection.
Cauley L, Murphy J
Infect Immun. 1979; 23(3):644-51.
PMID: 313367
PMC: 414213.
DOI: 10.1128/iai.23.3.644-651.1979.
